|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 409 12th Street, SW |
Address2 |
|
| City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
|
5. Senate ID# 400578740-12
|
||||||||
|
6. House ID# 412490000
|
||||||||
| TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Kira Peterson |
Date | 1/18/2024 3:13:05 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Abortion access (general); Access to Mifepristone (general); Contraception (general); Maternal Mortality and Morbidity (general); H.R. 1117, Advancing Safe Medications for Moms and Babies Act; obstetric and gynecologic care in rural areas (general; H.R. 3305/S. 1606, Black Maternal Health Momnibus Act; H.R. 952, Kids Access to Primary Care Act of 2023; H.R. 1202/S. 704, Resident Education Deferred Interest (REDI) Act; H.R. 4933/S. 462, Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023; H.R. 2389/S. 1302, Resident Physician Shortage Reduction Act of 2023; H.R. 2569, Doctors of Community (DOC) Act; Teaching Health Center Graduate Medication Education (general); physician workforce and training (general); H.R. 3838/S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023; H.R. 3226/S. 1573, PREEMIE Reauthorization Act of 2023; inclusion of pregnant and lactating individuals in research (general); Implementation of P.L. 115-320, Improving Access to Maternity Care Act; telemedicine (general); H.R. 5012/S. 2647, SHINE for Autumn Act; Rural Residency Planning and Development (RRPD) Program; H.R. 4581/S. 2231, Maternal and Child Health Stillbirth Prevention Act; Implementation of P.L. 117-328, Consolidated Appropriations Act, including the Pregnant Workers Fairness Act; Health Insurance Portability and Accountability Act (general); patient-physician relationship (general); H.R. 4605/S. 948, Healthy Moms and Babies Act; H.R. 4816/S. 2427, Convenient Contraception Act; Cost-sharing for maternity care (general); H.R. 4796/S. 2439, Reproductive Health Patient Navigator Act; H.R. 4731/S. 2386, Access to Infertility Treatment and Care Act; H.R. 5066, Tech to Save Moms Act; H.R. 4901/S. 2544, Reproductive Health Care Accessibility Act; Conscientious refusals in medicine (general); H.R. 834/S. 230, Rural Physician Workforce Production Act; menopause research (general); Alliance for Innovation on Maternal Health; Residency programs in obstetrics and gynecology (general); H.R. 5568/S. 2846, CARE for Moms Act; Value-based care models for obstetrics and gynecology (general); S. 3006, SAFE in Recovery Act; H.R. 4775, Helping Tobacco Users Quit Act; Treatment of reproductive health information under the Stored Communications Act (general); Congenital syphilis (general); Tax treatment of stillbirths (general); Substance use disorder during pregnancy (general); H.R. 117, NEWBORN Act; Physician burnout (general); Maternal mental health (general).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), White House Office, Executive Office of the President (EOP), Centers For Disease Control & Prevention (CDC), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Equal Employment Opportunity Commission (EEOC), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rebecca |
Lauer |
|
|
|
Erin |
Alston |
|
|
|
Taylor |
Platt |
|
|
|
Rachel |
Tetlow |
|
|
|
Lillie |
Hayman |
|
|
|
Lisa |
Satterfield |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2474, Strengthening Medicare for Patients and Providers Act; physician payment under Medicare (general); graduate medical education (general); S. 712, Connected MOM Act; Prior authorization in Medicare (general); H.R. 4585, Advancing Maternal Health Equity Under Medicaid Act; Conditions of participation in Medicare and Medicaid (general); Medicaid coverage for dental care (general); Medicaid free choice of provider requirement; Implementation of P.L. 117-328, Consolidated Appropriations Act, including permanent option for postpartum Medicaid extension.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rebecca |
Lauer |
|
|
|
Erin |
Alston |
|
|
|
Taylor |
Platt |
|
|
|
Rachel |
Tetlow |
|
|
|
Lillie |
Hayman |
|
|
|
Lisa |
Satterfield |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
H.R. 4268, MARCH for Servicemembers Act; H.R. 2670/S. 2226, FY2024 National Defense Authorization Act; Abortion care for servicemembers and dependents; Co-payments for contraceptives for TRICARE beneficiaries; Staffing at military medical treatment facilities; Military health professions scholarships and financial assistance programs; TRICARE payments to behavioral health professionals; Cost-sharing for outpatient mental health visits for TRICARE beneficiaries; Perinatal mental health of servicemembers and dependents; Mental and behavioral health services for servicemembers; Gamete cryopreservation for servicemembers.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rebecca |
Lauer |
|
|
|
Rachel |
Tetlow |
|
|
|
Lillie |
Hayman |
|
|
|
Erin |
Alston |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Abortion care at the Department of Veterans Affairs (general).
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rebecca |
Lauer |
|
|
|
Rachel |
Tetlow |
|
|
|
Lillie |
Hayman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 4942/S. 665, Conrad State 30 and Physician Access Reauthorization; H.R. 5008/S. 2646, HEAL for Immigrant Families Act of 2023; H.R. 3993/S. 2128, Stop Shackling and Detaining Pregnant Women Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rebecca |
Lauer |
|
|
|
Lillie |
Hayman |
|
|
|
Rachel |
Tetlow |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Alliance for Innovation on Maternal Health; Safe Motherhood and Infant Health Program; Centers for Disease Control and Prevention (general); National Institutes of Health (general); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Agency for Healthcare Research & Quality (AHRQ); National Health Service Corps; Teaching Health Center Graduate Medical Education Program; National Maternal Mental Health Hotline; Screening and Treatment for Maternal Mental Health and Substance Use Disorders Program; Congressionally Directed Medical Research Program; Office of Adolescent Health (general); Office of Population Affairs (general); Title X family planning program (general); International family planning programs; Contraceptive research; Helms amendment; United Nations Population Fund; Kemp-Kasten amendment; HIV/AIDS Working Capital Fund; Siljander amendment; Livingston amendment; Prevention and Public Health Fund; Advanced Research Projects Agency for Health (general); Title V Maternal and Child Health Block Grant; Special Supplemental Nutrition Program for Women, Infants, and Children (WIC); Teen Pregnancy Prevention Program, Division of STD Prevention at CDC; Division of Adolescent and School Health; Sexual Risk Avoidance Education Program; sexually transmitted disease (STD) prevention (general); National Center for Health Statistics (NCHS); H.R. 5894/S. 2624, FY2024 Labor, Health and Human Services, and Education, and Related Agencies appropriations bill; H.R. 4368/S. 2131, FY2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill; H.R. 4665/S. 2438, FY2024 State, Foreign Operations, and Related Programs appropriations bill; H.R. 4365/S. 2587, FY2024 Defense appropriations bill; H.R. 4366/S. 2127, FY2024 Military Construction, Veterans Affairs, and Related Agencies appropriations bill.
17. House(s) of Congress and Federal agencies Check if None
Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Tetlow |
|
|
|
Rebecca |
Lauer |
|
|
|
Lillie |
Hayman |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |